Translartion. Region: Russians Fedetion –
Source: Center for Diagnostics and Telemedicine
Researchers from Moscow have confirmed the effectiveness of telemedicine in the treatment of inflammatory bowel disease (IBD), demonstrating that remote monitoring and online consultations can significantly improve patient outcomes.
Center for Diagnostics and Telemedicine.
A recent study found that patients who received care through a specialized telemedicine platform reported lower levels of anxiety, better treatment adherence, and overall improved quality of life compared to those who received traditional in-person consultations.
At the same time, studies show that remote monitoring is comparable to in-person monitoring in its ability to reduce disease activity and improve quality of life.
In a recent study involving more than 60 patients diagnosed with inflammatory bowel disease, scientists compared two different treatments.
One group received traditional face-to-face consultations, while the other used a specialized medical web platform. This platform allowed patients to report their health status and participate in online consultations with gastroenterologists.
The aim of the study was to assess a range of well-being indicators, including quality of life, levels of anxiety and depression, patient satisfaction with health care and adherence to prescribed medication regimens.
The experiment was conducted jointly with the Center for Diagnostics and Telemedicine and the First Moscow State Medical University named after I.M. Sechenov.
The results of the study showed a significant reduction in anxiety levels in the telemedicine group, by 30% compared to the face-to-face group. In addition, depression decreased by 29%, and colon pain sensitivity by 27%. Notably, both groups experienced a reduction in disease severity.
According to Yuri Vasiliev, General Director of the Center for Diagnostics and Telemedicine of the Moscow Department of Health and Chief Consultant for Radiology of the Moscow Department of Health, the results obtained clearly demonstrated the benefits of remote treatment.
“The results obtained highlight the effectiveness of telemedicine in the treatment of inflammatory bowel diseases,” Vasiliev noted.
“By using digital platforms, patients can have more convenient access to treatment, which can lead to improved psychological outcomes and greater adherence to treatment plans.”
This design allows for a comprehensive assessment of the impact of telemedicine on the treatment of inflammatory bowel diseases in the context of Russian healthcare.
The study began in 2023 and is part of Moscow’s broader efforts to integrate telemedicine and artificial intelligence into healthcare.
This study adds to the growing body of evidence supporting the role of telemedicine in chronic disease management, highlighting its potential to increase access, improve patient outcomes and reduce the burden on health systems.
The Diagnostics and Telemedicine Center, established in 1996, is a leading scientific and practical organization within the Moscow City Hall Social Development Complex. The Center is engaged in the implementation of artificial intelligence in medicine, the development of radiology and medical personnel training programs.